Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of BIA 6-512 in Healthy Young vs Elderly Subjects
NCT03095105Phase 1Completed
- Sponsor
- BIAL
- Start
- Jan 2006
- Primary completion
- Mar 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of resveratrol in Parkinson's disease (PD) (2 arms), sponsored by BIAL. Primary endpoints: Maximum Observed Plasma Concentration at Day 4, Area Under the Plasma Concentration-Time Curve Over the Dosing Interval at Day 4 and 1 more. Started Jan 2006; status: completed.
02
Drugs
resveratrol
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT03095105.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03095105.